Table 1.
The distribution of the viral pathogens at the patients during COVID-19 pandemics
| Detected viral agents | Frequency of detected viral agents (n) | Percentage of viruses among detected viral agents (%) n: 321* | Percentage of viruses detected in patients included in the study (%) n: 513* |
|---|---|---|---|
| SARS-CoV-2 | 122 | 38 | 23.8 |
| Rhinovirus | 156 | 48.6 | 30.4 |
| RSV | 18 | 5.6 | 3.5 |
| Enterovirus | 9 | 2.8 | 1.7 |
| Human metapneumovirus | 7 | 2.18 | 1.4 |
| Adenovirus | 7 | 2.18 | 1.4 |
| Parainfluenza | 5 | 1.55 | 1.0 |
| Bocavirus | 2 | 0.6 | 0.4 |
| Coronavirus OC43 | 2 | 0.6 | 0.4 |
| Influenza virus | 2 | 0.6 | 0.4 |
| Paraechovirus | 1 | 0.3 | 0.2 |
| Negative PCR results | 193 | 37.6 | |
| Total | 524* |
PCR, polymerase chain reaction; RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2.
⁎
A total of 11 patients had co-detection with more than 1 virus.